A detailed history of Charles Schwab Investment Management Inc transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 567,063 shares of PSTX stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
567,063
Previous 545,808 3.89%
Holding current value
$5.36 Million
Previous $1.59 Million 1.76%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.7 - $4.04 $57,388 - $85,870
21,255 Added 3.89%
567,063 $1.62 Million
Q2 2024

Aug 12, 2024

BUY
$2.0 - $3.46 $26,430 - $45,723
13,215 Added 2.48%
545,808 $1.59 Million
Q1 2024

May 08, 2024

BUY
$2.76 - $4.13 $63,010 - $94,287
22,830 Added 4.48%
532,593 $1.7 Million
Q4 2023

Feb 06, 2024

BUY
$1.83 - $3.51 $12,237 - $23,471
6,687 Added 1.33%
509,763 $1.71 Million
Q3 2023

Nov 08, 2023

BUY
$1.62 - $2.79 $119,070 - $205,065
73,500 Added 17.11%
503,076 $1.2 Million
Q2 2023

Aug 09, 2023

BUY
$1.66 - $3.4 $280,257 - $574,022
168,830 Added 64.75%
429,576 $756,000
Q1 2023

May 11, 2023

SELL
$3.08 - $8.73 $11,799 - $33,444
-3,831 Reduced 1.45%
260,746 $803,000
Q4 2022

Feb 13, 2023

BUY
$3.33 - $6.38 $17,602 - $33,724
5,286 Added 2.04%
264,577 $1.4 Million
Q3 2022

Nov 14, 2022

BUY
$2.43 - $4.51 $308,298 - $572,192
126,872 Added 95.81%
259,291 $916,000
Q2 2022

Aug 15, 2022

SELL
$1.87 - $5.0 $163,944 - $438,355
-87,671 Reduced 39.83%
132,419 $342,000
Q1 2022

May 13, 2022

BUY
$3.22 - $7.04 $26,819 - $58,636
8,329 Added 3.93%
220,090 $987,000
Q4 2021

Feb 11, 2022

BUY
$6.23 - $7.6 $17,605 - $21,477
2,826 Added 1.35%
211,761 $1.44 Million
Q3 2021

Nov 16, 2021

BUY
$7.09 - $10.71 $573,368 - $866,117
80,870 Added 63.15%
208,935 $1.52 Million
Q2 2021

Aug 16, 2021

SELL
$7.96 - $10.07 $107,069 - $135,451
-13,451 Reduced 9.5%
128,065 $1.28 Million
Q1 2021

May 17, 2021

BUY
$8.51 - $11.91 $442,843 - $619,772
52,038 Added 58.16%
141,516 $1.35 Million
Q4 2020

Feb 16, 2021

BUY
$8.29 - $11.7 $12,434 - $17,550
1,500 Added 1.7%
89,478 $982,000
Q3 2020

Nov 13, 2020

BUY
$8.09 - $16.25 $711,742 - $1.43 Million
87,978 New
87,978 $781,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $811M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.